Varenne Capital Partners Takes $1.24 Million Position in GE HealthCare Technologies Inc. $GEHC

Varenne Capital Partners bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 16,531 shares of the company’s stock, valued at approximately $1,241,000. GE HealthCare Technologies comprises 0.2% of Varenne Capital Partners’ investment portfolio, making the stock its 23rd largest position.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Godsey & Gibb Inc. acquired a new stake in GE HealthCare Technologies during the 3rd quarter valued at $26,000. E Fund Management Hong Kong Co. Ltd. raised its position in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the period. Allianz SE raised its position in shares of GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares during the period. Oakworth Capital Inc. lifted its stake in shares of GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after buying an additional 394 shares during the last quarter. Finally, Piscataqua Savings Bank boosted its holdings in shares of GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after buying an additional 300 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $78.13 on Wednesday. The stock has a market capitalization of $35.61 billion, a PE ratio of 17.13, a PEG ratio of 1.76 and a beta of 1.03. The business’s 50 day simple moving average is $82.20 and its 200 day simple moving average is $78.54. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the previous year, the company earned $1.45 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Barclays increased their price target on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Bank of America upped their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Finally, Piper Sandler raised their target price on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.